NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
511 Trollhättan

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 45 1.0% 12 0.3% 7 0.2% . . . . 2 0.0% 4584 98.6% 4650 100.0%
ASCUS 105 22.7% 95 20.5% 47 10.2% . . . . 3 0.6% 213 46.0% 463 100.0%
LSIL 41 19.1% 47 21.9% 45 20.9% . . . . . . 82 38.1% 215 100.0%
Atypical glandular cells/AGC 4 57.1% 2 28.6% 1 14.3% . . . . . . . . 7 100.0%
ASC-H 14 29.8% 8 17.0% 24 51.1% . . . . . . 1 2.1% 47 100.0%
HSIL 7 10.8% 6 9.2% 47 72.3% 1 1.5% 3 4.6% . . 1 1.5% 65 100.0%
Totalt 216 4.0% 170 3.1% 171 3.1% 1 0.0% 3 0.1% 5 0.1% 4881 89.6% 5447 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the
category Cancer:
M80703, M81403